Matches in Wikidata for { <http://www.wikidata.org/entity/Q37218730> ?p ?o ?g. }
- Q37218730 description "article científic" @default.
- Q37218730 description "article scientifique" @default.
- Q37218730 description "articolo scientifico" @default.
- Q37218730 description "artigo científico" @default.
- Q37218730 description "artículu científicu espublizáu en 2012" @default.
- Q37218730 description "bilimsel makale" @default.
- Q37218730 description "scientific article published on 26 January 2012" @default.
- Q37218730 description "vedecký článok" @default.
- Q37218730 description "vetenskaplig artikel" @default.
- Q37218730 description "videnskabelig artikel" @default.
- Q37218730 description "vědecký článek" @default.
- Q37218730 description "wetenschappelijk artikel" @default.
- Q37218730 description "wissenschaftlicher Artikel" @default.
- Q37218730 description "наукова стаття, опублікована в січні 2012" @default.
- Q37218730 description "научни чланак" @default.
- Q37218730 description "مقالة علمية نشرت في 26 يناير 2012" @default.
- Q37218730 name "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 name "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 name "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 type Item @default.
- Q37218730 label "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 label "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 label "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 prefLabel "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 prefLabel "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 prefLabel "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 P1433 Q37218730-BA75D51D-4570-40F8-8DC3-5A86B0AE8B72 @default.
- Q37218730 P1476 Q37218730-0C50394A-164A-4E36-A264-0E3AF143DDAA @default.
- Q37218730 P2093 Q37218730-0104A459-9789-40F1-9B3E-7341F9514077 @default.
- Q37218730 P2093 Q37218730-0D24CE63-5601-4A98-8C82-D520C49115B8 @default.
- Q37218730 P2093 Q37218730-1B391482-30EA-4D4C-AA68-F9B8D112D5AC @default.
- Q37218730 P2093 Q37218730-35B7D422-A337-43F1-91F2-FFF06A261A6B @default.
- Q37218730 P2093 Q37218730-5A13885A-80F8-44DF-85DC-D6FCD8C6F795 @default.
- Q37218730 P2093 Q37218730-8BA010A4-6D9C-4D1D-9AFF-DFA667DD3F7B @default.
- Q37218730 P2093 Q37218730-9E7B661C-71EB-4D15-82B3-82BB08FEA87C @default.
- Q37218730 P2093 Q37218730-D72D4741-358D-4D4A-83CD-0B7D67326DC7 @default.
- Q37218730 P2093 Q37218730-D775C18B-6403-4685-8BAE-2368F6345E4C @default.
- Q37218730 P2093 Q37218730-F00306C8-170A-4638-A4F5-15A44909E3DC @default.
- Q37218730 P2860 Q37218730-0A095A30-5C56-409D-A195-391BBB0B26B0 @default.
- Q37218730 P2860 Q37218730-13CA29A6-B748-4E6D-A7EC-C5C5C77F9B93 @default.
- Q37218730 P2860 Q37218730-145379BC-1404-482A-8596-28E2C6E62B78 @default.
- Q37218730 P2860 Q37218730-1CA54983-93CC-496A-B764-88479F83F7D4 @default.
- Q37218730 P2860 Q37218730-2373EEC9-93AF-4C96-BC3E-07BA41DC3EAD @default.
- Q37218730 P2860 Q37218730-280F750E-19E5-41F9-9212-A8A8839910FF @default.
- Q37218730 P2860 Q37218730-392B3896-47CC-4AC7-860A-2A194366F4CF @default.
- Q37218730 P2860 Q37218730-54327C14-D799-4D14-8FD6-3ED529DA77EB @default.
- Q37218730 P2860 Q37218730-5ACCEA67-D140-4742-88E1-BAE6BA65955E @default.
- Q37218730 P2860 Q37218730-69C1D711-ABFE-469A-92B1-5755AA8D053A @default.
- Q37218730 P2860 Q37218730-6A5D7CA4-D57F-48A7-B977-A38BAD70F25F @default.
- Q37218730 P2860 Q37218730-7B3E9139-EB58-457E-B853-1AAC299E8C01 @default.
- Q37218730 P2860 Q37218730-86CBE603-00E0-48C7-A5F9-21D2A57DF501 @default.
- Q37218730 P2860 Q37218730-8A84D9CD-767D-4146-B855-D6D6F57682ED @default.
- Q37218730 P2860 Q37218730-A02FBF11-7B74-4256-ACDE-6812343D9EDD @default.
- Q37218730 P2860 Q37218730-A360DFAC-5F36-4F8E-8B3C-3AF65395C00B @default.
- Q37218730 P2860 Q37218730-A67D944C-7F76-4E62-A2E8-C8854ECF2349 @default.
- Q37218730 P2860 Q37218730-AD60F483-E269-4D09-B658-6CD48FD311CA @default.
- Q37218730 P2860 Q37218730-B32BC373-D671-438C-A50D-32390AACF21D @default.
- Q37218730 P2860 Q37218730-BA598A59-DF46-4D45-8E26-B8D90B382B99 @default.
- Q37218730 P2860 Q37218730-BA7D53BA-A7D0-4703-A12D-D14C3F18B5E4 @default.
- Q37218730 P2860 Q37218730-BAEDF5B9-9B3C-4C20-83C4-DF881B3705F9 @default.
- Q37218730 P2860 Q37218730-BD499AF4-465F-42C1-B3E7-5E23172E292C @default.
- Q37218730 P2860 Q37218730-BDF01E81-B802-418D-AAB4-37387416B641 @default.
- Q37218730 P2860 Q37218730-BFA7375D-053E-4478-B572-C47C8203C92D @default.
- Q37218730 P2860 Q37218730-CC9F2071-94A6-456B-B020-56AC766AB0A0 @default.
- Q37218730 P2860 Q37218730-D3706E7F-5B57-48FC-9051-9A64B0D82AD0 @default.
- Q37218730 P2860 Q37218730-FFD52B69-F67D-4D41-9F31-B5DAADF92DC5 @default.
- Q37218730 P304 Q37218730-B3F02187-940F-4140-87B5-3DADB8FAEB21 @default.
- Q37218730 P31 Q37218730-90806B8A-AEE5-4FCA-94B4-AF4D6EC17334 @default.
- Q37218730 P356 Q37218730-03F3CB3A-5350-48DA-B514-E6D8BC7B92D8 @default.
- Q37218730 P407 Q37218730-BB7F67DD-A865-4B90-9D55-2A4A80044F70 @default.
- Q37218730 P433 Q37218730-E2B37E35-8940-4C1A-AB68-CEE0723BF289 @default.
- Q37218730 P478 Q37218730-515BB26A-43E3-4944-904D-0AD22DAF29B6 @default.
- Q37218730 P50 Q37218730-95007F44-3D97-4BB5-A30E-BD0A689A389F @default.
- Q37218730 P50 Q37218730-B0E2929D-0A58-4CE3-B7A9-BA54A49448EE @default.
- Q37218730 P50 Q37218730-E337094E-741A-4E7D-8AB0-DF5ECF97FC70 @default.
- Q37218730 P50 Q37218730-E700AACD-D8D3-48CB-9B67-C5D181BD9EB1 @default.
- Q37218730 P577 Q37218730-46CD7A00-2D95-44A5-9CC8-C67219387FA1 @default.
- Q37218730 P5875 Q37218730-16B079FA-49AB-4666-A7C7-5827386FC99E @default.
- Q37218730 P698 Q37218730-0A1972CF-1ADF-4128-82DB-03DB9FF839E2 @default.
- Q37218730 P921 Q37218730-1C45D719-4587-495C-836E-38D7CA7F869C @default.
- Q37218730 P921 Q37218730-8E83571F-78E0-4DD9-A79F-0E9842B85067 @default.
- Q37218730 P921 Q37218730-C6DA690F-C9D2-42A9-BB7E-A76C1DB376E5 @default.
- Q37218730 P921 Q37218730-F71530FD-F0DC-47CB-9D4D-A47E1E5F7802 @default.
- Q37218730 P932 Q37218730-BBADFC73-B12B-41AF-B4B3-B17EF1231848 @default.
- Q37218730 P356 CNCR.27416 @default.
- Q37218730 P698 22282219 @default.
- Q37218730 P1433 Q326041 @default.
- Q37218730 P1476 "Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial" @default.
- Q37218730 P2093 "Clare M Tempany" @default.
- Q37218730 P2093 "Fiona M Fennessy" @default.
- Q37218730 P2093 "Julia Hayes" @default.
- Q37218730 P2093 "Marc Barry" @default.
- Q37218730 P2093 "Matthew D Galsky" @default.
- Q37218730 P2093 "Phil Febbo" @default.
- Q37218730 P2093 "Robert W Ross" @default.
- Q37218730 P2093 "Rupal S Bhatt" @default.
- Q37218730 P2093 "Wanling Xie" @default.
- Q37218730 P2093 "William K Oh" @default.
- Q37218730 P2860 Q27860681 @default.
- Q37218730 P2860 Q28278736 @default.